Company profile: Liquid Biosciences
1.1 - Company Overview
Company description
- Provider of a bio-analytics platform supporting healthcare projects and collaborations with biopharma, diagnostic, clinical research, and academic institutions; biomarker discovery to aid diagnostics and therapeutic development; and drug rescue and development acceleration services.
Products and services
- Bio-Analytics Platform: A research-grade, sophisticated bio-analytics system that supports healthcare projects and collaborations with biopharma, diagnostic, clinical research, and academic institutions
- Drug Rescue and Development Acceleration: Custom-engineered services focused on rescuing failed drugs and speeding up the development of new pharmaceuticals, with defined emphasis on rescue and acceleration objectives
- Biomarker Discovery: A data-driven program that identifies novel biomarkers for various diseases, supporting diagnostics and therapeutic development through targeted identification
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Liquid Biosciences
Benchling
HQ: United States
Website
- Description: Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benchling company profile →
ValGenesis
HQ: United States
Website
- Description: Provider of an enterprise validation life-cycle management system that electronically manages the entire validation life-cycle from start to end. Automates validation to reduce cycle time and cost by at least 40 - 50%, enhances compliance, improves consistency, and standardizes corporate validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ValGenesis company profile →
Seismic Therapeutic
HQ: United States
Website
- Description: Provider of machine-learning technology for immunology drug development, offering the IMPACT platform to accelerate novel biologics by integrating machine learning with structural biology, protein engineering, and translational immunology; Ig Sculpting Enzymes to modify pathogenic antibodies in autoimmune diseases, optimized for reduced immunogenicity while retaining enzyme activity; and Dual-cell Bidirectional antibodies engaging multiple inhibitory pathways in immune cells to restore immune homeostasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seismic Therapeutic company profile →
eClinical Insights
HQ: United States
Website
- Description: Provider of cloud-based clinical software products offering a business analytic engine, data visualization application, and trial management services to organizations to optimize the performance of clinical trials, project teams, clinical systems, and service providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eClinical Insights company profile →
CoreBiome
HQ: United States
Website
- Description: Provider of fast, accurate genomic profiles of microbial communities (microbiomes) for pharmaceutical, agriculture, and academic research customers, using proprietary reagents and informatics to enable rapid, affordable, and highly accurate measurement and interpretation of microbial diversity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoreBiome company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Liquid Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Liquid Biosciences
2.2 - Growth funds investing in similar companies to Liquid Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Liquid Biosciences
4.2 - Public trading comparable groups for Liquid Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →